Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHL TelemedicineSHMLF 54 Revenue per Share is $1.78 as of Dec. 2025. GuruFocus rates SHMLF with a GF Score™ of 54/100 and a GF Value™ of $11.97. The stock has 5 warning signs investors should review. Among 611 Healthcare Providers & Services companies, SHL Telemedicine ranks worse than 66.45% on this metric.
SHL Telemedicine's revenue per share for the
six
months ended in Dec. 2025 was $0.83.
SHL Telemedicine's revenue per share for the trailing twelve months (TTM) ended in Dec. 2025 was $1.78.
Warning Sign:
SHL Telemedicine Ltd revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue Per Share Growth Rate of SHL Telemedicine was -13.20% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was 2.00% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was 4.70% per year.
During the past 10 years, the average Revenue Per Share Growth Rate was 0.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for SHL Telemedicine's Revenue per Share or its related term are showing as below:
SHMLF'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -26.5 Med: -1.6 Max: 15.8
Current: 2
During the past 13 years, SHL Telemedicine's highest 3-Year average Revenue Per Share Growth Rate was 15.80% per year. The lowest was -26.50% per year. And the median was -1.60% per year.
SHMLF's 3-Year Revenue Growth Rate is ranked worse than 66.45% of 611
companies
in the Healthcare Providers & Services industry
Industry Median: 7
vs SHMLF: 2.00
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
SHL Telemedicine Revenue per Share Related Terms
SHL Telemedicine Revenue per Share Historical Data
* Premium members only.
The historical data trend for SHL Telemedicine's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHMLF vs VEEV, BTSG, HQY: Revenue per Share Comparison
For the Health Information Services subindustry, SHL Telemedicine's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SHL Telemedicine PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, SHL Telemedicine's PS Ratio distribution charts can be found below:
* The bar in red indicates where SHL Telemedicine's PS Ratio falls into.
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
SHL Telemedicine's Revenue Per Share for the fiscal year that ended in Dec. 2025 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $1.78
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHL Telemedicine (SHMLF) has a Revenue per Share of $1.78 as of Dec. 2025. Revenue per share equals the per-share value of a company's sales. View historical data on SHL Telemedicine and its competitors. According to the industry distribution chart, SHL Telemedicine ranks #406 out of 611 companies in the Healthcare Providers & Services industry, placing it in the top 66.4%.
Is SHL Telemedicine's Revenue per Share too high?
SHL Telemedicine's current Revenue per Share is $1.78. The Healthcare Providers & Services industry median Revenue per Share is 7.00. SHL Telemedicine's value of $1.78 is 74.6% below this industry median. Based on the distribution chart, SHL Telemedicine ranks #406 out of 611 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, SHL Telemedicine has a GF Score™ of 54/100, reflecting its overall financial health beyond just this single metric.
How does SHL Telemedicine's Revenue per Share compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, SHL Telemedicine ranks #406 out of 611 companies for Revenue per Share. This places SHL Telemedicine in the lower half of its industry. The industry median Revenue per Share is 7.00. SHL Telemedicine's value of $1.78 is 74.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue per Share for a Healthcare Providers & Services company?
The median Revenue per Share among Healthcare Providers & Services companies is 7.00, based on 611 companies in the industry. Companies in the top quartile (top 25%) have a Revenue per Share significantly above this median, while those in the bottom quartile fall well below. However, Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SHL Telemedicine's current Revenue per Share of $1.78 is 74.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue per Share mean?
A high Revenue per Share can signal that a stock is expensive relative to its fundamentals. Revenue per share equals the per-share value of a company's sales. View historical data on SHL Telemedicine and its competitors. For the Healthcare Providers & Services industry, the median Revenue per Share is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SHL Telemedicine's current Revenue per Share is $1.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SHL Telemedicine stock overvalued right now?
SHL Telemedicine (SHMLF) has a current Revenue per Share of $1.78. The stock's GF Value™ is $11.97, compared to a current price of $4.84 — trading 59.5% below its estimated fair value. The current Revenue per Share is $1.78 and 74.6% below the Healthcare Providers & Services industry median of 7.00. SHL Telemedicine's overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue per Share calculated?
Revenue per Share is calculated from a company's financial statements. For SHL Telemedicine (SHMLF), the current Revenue per Share is $1.78 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SHL Telemedicine (SHMLF) Overvalued in 2026?
Based on GuruFocus' analysis, SHL Telemedicine stock appears to be undervalued.
The current stock price of $4.84 is trading 59.5% below its estimated GF Value™ of $11.97.
Key valuation signals for SHMLF:
Revenue per Share: $1.78
GF Value™: $11.97 vs. price of $4.84 (59.5% below fair value)
Industry Position: 74.6% below the Healthcare Providers & Services median (#406 of 611)
No single metric tells the full story. See the SHMLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. The company consists of the transmission of medical data by an individual, from a remote location to a medical call center, through telecommunication networks. The company provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments are Israel, Europe, and the rest of the world, out of which majority of revenue comes from Israel.
54GF Score
Get the complete analysis for SHMLF
Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHMLF has been successfully added to your 
